Article

Improved cataract surgery lowers infection rates

Endophthalmitis continues to be rare after cataract surgery, according to a study by Canadian researchers.

San Francisco-Endophthalmitis continues to be rare after cataract surgery, according to a study by Canadian researchers. Surgical techniques and patient selection criteria have evolved rapidly in the past several years and researchers wanted to learn whether infection risks were changing as a result.

Records were reviewed of more than 440,000 consecutive cataract surgeries performed in surgical facilities in Ontario, Canada between April 2002 and March 2006. Facilities where more than 50 cataract surgeries were performed were included.

Postoperative procedures to treat suspected infection that occurred within 14 days of cataract surgery were tracked by the study. The overall rate of suspected acute endophthalmitis was very low: 1.4 per 1,000 surgeries.

Patients who required correction of ruptures of their lens capsule during cataract surgery were about 10 times more likely to develop suspected infection, but fewer than 1 in 200 sustained such a rupture. The highest rate of suspected endophthalmitis occurred in patients aged 85 or more years (2.18 per 1,000).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.